• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sage Therapeutics Inc

+ Add to Watchlist

SAGE:US

26.9000 USD 0.7000 2.54%

As of 12:57:16 ET on 07/31/2014.

Snapshot for Sage Therapeutics Inc (SAGE)

Open: 27.5000 Day's Range: 26.6500 - 27.5000 Volume: 52,661
Previous Close: 27.6000 52wk Range: 24.2500 - 30.7500 1-Yr Rtn: -

Stock Chart for SAGE

No chart data available.
  • SAGE:US 26.9000
  • 1D
  • 1M
  • 1Y
27.6000
Interactive SAGE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAGE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 707.08
Shares Outstanding (M) 25.71
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAGE

No data available

Company Profile & Key Executives for SAGE

Sage Therapeutics Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Jeffrey M Jonas "Jeff"President/CEOKimi IguchiChief Financial Officer
Stephen J KanesChief Medical OfficerAlbert J RobichaudChief Scientific Officer
More Company Profile & Key Executives for SAGE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • SAGE News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil